Shuttle Pharmaceuticals | PRER14A:初步修訂代理權徵集材料
Shuttle Pharmaceuticals | 8-K:Shuttle Pharma將於2025年4月23日參加Planet MicroCap Showcase:VEGAS 2025
Shuttle Pharmaceuticals | DEFR14A:修正後委託徵集材料
Shuttle Pharmaceuticals | PRER14A:初步修訂代理權徵集材料
Shuttle Pharmaceuticals | 8-K:Shuttle Pharmaceuticals申請了用於治療前列腺癌PSMA配體偶聯物的臨時專利
Shuttle Pharmaceuticals | 8-K:諮詢協議
Shuttle Pharmaceuticals | 3:首次持股聲明-高管 Cooper Chris
Shuttle Pharmaceuticals | ARS:年度報告
Shuttle Pharmaceuticals | DEF 14A:股東委託書決議
Shuttle Pharmaceuticals | 8-K:經修訂和重述的僱傭協議
Shuttle Pharmaceuticals | 8-K:諮詢協議
Shuttle Pharmaceuticals | 3:首次持股聲明-董事 Tung Joseph
Shuttle Pharmaceuticals | 3:首次持股聲明-董事 Nabyt Oleh
Shuttle Pharmaceuticals | 3:首次持股聲明-董事 Scorsis George
Shuttle Pharmaceuticals | PRE 14A:並購重組委托聲明
Shuttle Pharmaceuticals | 8-K:Shuttle Pharmaceuticals宣佈完成575萬美元承銷發行
Shuttle Pharmaceuticals | 424B3:募資說明書
Shuttle Pharmaceuticals | 8-K:Shuttle Pharmaceuticals宣布任命Christopher Cooper為臨時聯合執行長以加強業務活動
Shuttle Pharmaceuticals | EFFECT:其他
Shuttle Pharmaceuticals | CORRESP:信函